Skip to main content
Recall Canary
Clomiphene Citrate USP Active Pharmaceutical Ingredient
← Back to all recalls
DRUG RECALLMODERATE

Clomiphene Citrate USP Active Pharmaceutical Ingredient

Shimoga Chemicals is recalling Clomiphene Citrate USP Active Pharmaceutical Ingredient due to cGMP deviations.

What to do

Stop using the affected active pharmaceutical ingredient and contact the manufacturer for further instructions.

Posted
Updated
Recall No.
D-0691-2026
Agency
Firm
Shimoga Chemicals
Recall ID
99232
Status
ONGOING

Why it was recalled

Shimoga Chemicals is recalling Clomiphene Citrate USP Active Pharmaceutical Ingredient due to current good manufacturing practice (cGMP) deviations. The affected products are available in three different net weights.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), Net Weight a)1 KG (NDC 84849-000-01), b) 500 g (NDC 84849-000-02), (c) 100 g (NDC 84849-000-03), Rx Only, Shimoga Chemicals Address -W-57A, MIDC Kupwad Samgli, Maharashtra, 416436, India.

Recall #
D-0691-2026

Where it was sold

Distributed in California and Florida.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-07-08 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification